Market Research Report
Global Osteoporosis Market, Patients, Companies & Forecast
|Published by||Renub Research||Product code||210160|
|Published||Content info||124 Pages; 89 Figures; 8 Tables
Delivery time: 1-2 business days
|Global Osteoporosis Market, Patients, Companies & Forecast|
|Published: September 24, 2015||Content info: 124 Pages; 89 Figures; 8 Tables||
Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.
This is the 2nd edition report on Osteoporosis by Renub Research. Report titled "Global Osteoporosis Market, Patients, Companies & Forecast" provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points:
Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephonic interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.